The number of disorders for which molecular genetic testing is possible is increasing rapidly. The laboratory monitors the situation and reviews the services accordingly. Please contact the laboratory for an updated list of services provided. There is an organised UK network (UKGTN) for testing for rare disorders and the laboratory has arrangements with other centres for tests not included on the list below. Please contact the laboratory for details. Other useful sources of information are the UK directory of molecular genetic services maintained by the Clinical Molecular Genetics Society (www.cmgs.org) and the OrphaNet database (www.orpha.net)
The preferred sample type is 3ml blood (1-2 ml from small children) collected into EDTA, though other samples may be suitable. Please contact the laboratory for further details.
|
Diagnostic testing for mutations in ABCD1 gene |
|
|
Familial mutation studies |
|
|
Aneuploidy screening (PCR based) |
|
|
Screening for trisomy 13, 18 & 21 plus sex chromosome
aneuploidies |
|
|
BRCA1 & 2: Familial mutation studies only. Referrals only
accepted from Clinical Genetics Department |
|
|
Diagnostic testing for mutations in Notch3 gene |
|
|
Familial mutation studies |
|
|
Diagnostic testing and carrier detection for
28 common CFTR mutations. Other rarer mutations by specific request |
|
|
Testing for CAG expansion mutation |
|
|
Diagnostic testing and carrier detection for deletion /
duplication mutation plus linkage analysis where necessary |
|
|
Diagnostic testing for DYT1 mutation in Torsion Dystonia |
|
|
Service for Myoclonic Dystonia under development) |
|
|
APC gene familial mutation studies only. Referrals only accepted
from Clinical Genetics Department |
|
|
Diagnostic testing and carrier detection for Frax A mutation. Frax E testing if specifically requested. |
|
|
Diagnostic & carrier testing for the GAA expansion mutation |
|
|
Point mutation analysis in FXN gene |
|
|
Testing for TATAA box mutation in UGT1A1 gene |
|
|
Testing for V617F mutation in JAK2
gene. (JAK2 Exon 12 mutations : contact laboratory). |
|
|
Testing for ITD mutation in FLT3
gene |
|
|
Testing for B cell IgH clonal
rearrangements by PCR. (T cell clonal rearrangement testing: contact laboratory) |
|
|
Testing for C282Y mutation and H63D if indicated |
|
|
Diagnostic testing for Connexin 26 and 30 gene mutations |
|
|
Familial mutation studies for Connexin 26 gene |
|
|
Diagnostic testing for Mitochondrial mutation m.1555A>G |
|
|
Testing for common 17p duplication
and deletion |
|
|
Testing for mutations in PMP22, MPZ, GJB1 and
Mitofusin
genes |
|
|
Familial mutation studies for the above genes |
|
|
Referrals only accepted from Clinical Genetics Department |
|
|
Testing for CAG expansion mutation. Pre-symptomatic Referrals only accepted from Clinical Genetics Department |
|
|
Testing for CAG expansion mutation |
|
|
Diagnostic testing for 3 common mutations |
|
|
Testing for common c.985A>G mutation only |
4 weeks |
|
Mitochondrial disease |
|
|
Testing for common point mutations associated with MELAS, MERRF, NARP.
Testing for mitochondrial genomic rearrangements (muscle biopsy preferred). |
|
|
Testing for CTG expansion mutation |
|
|
Diagnostic testing for mutations in MTM1 gene |
|
|
Familial mutation studies |
|
|
Diagnostic testing for mutations in LMX1B gene |
|
|
Familial mutation studies |
|
|
Testing for c.408insA mutation in FTL gene |
|
|
Testing for PRSS1
mutations |
|
|
Diagnostic testing for mutations in STK11 gene |
|
|
Familial mutation studies |
|
|
Diagnostic testing for mutations in PANK2 gene |
|
|
Familial mutation studies |
|
|
Diagnostic testing using methylation studies |
|
|
Family studies on positive cases by microsatellite analysis |
|
|
Diagnostic and carrier testing for SMN1 deletions |
|
|
Testing for SCA1, SCA2, SCA3
and SCA6
CAG expansion mutations (SCA7 and
SCA17
testing by specific request only) |
|
|
Testing for loss/gain of sub-telomeric regions of all
chromosomes by MLPA analysis |
|
|
Uniparental disomy studies |
|
|
4 weeks |
|
|
Testing for rearrangements of chromosomes 1p, 3, 6 and 8 by MLPA
analysis |
4 weeks |
|
Zygosity / Paternity analysis |
|
|
Zygosity and Paternity testing is only available for clinical
not social/legal cases |
4 weeks |
Revised 30.11.08 (David Gokhale)
Reviewed 30.11.08 (David Gokhale)
Reviewed 25.02.09 (David Gokhale)





